Expansion potential Emerging neurorehabilitation focus with recent US product launch and ongoing device portfolio suggests opportunities to expand sales channels and partnerships in North America, particularly with clinics treating stroke and spinal cord injury.

Clinical care alignment Products target upper extremity rehabilitation and neuroprotection, aligning with hospital and rehab center needs for hands-on therapy devices and pressure injury prevention, enabling upsell to interdisciplinary teams.

Strategic funding signals Recent investments from Genome BC and oversubscribed rounds indicate investor confidence and potential leverage for grant-supported trials or reimbursement pilots, which can accelerate procurement decisions in care networks.

Small team agility With a compact team, Rehabtronics can offer responsive support, rapid product iterations, and personalized onboarding to key accounts, while pursuing channel partnerships to scale reach without heavy internal overhead.

Competitive positioning Comparative peers in medical device rehabilitation space show a range of revenue and personnel; Rehabtronics can differentiate through neuroscience-backed devices like ReGrasp and Prelivia trials to demonstrate clinical and cost-benefit advantages.